Related references
Note: Only part of the references are listed.Current perspectives on parathyroid hormone (PTH) and PTH-related protein (PTHrP) as bone anabolic therapies
Pedro Esbrit et al.
BIOCHEMICAL PHARMACOLOGY (2013)
Discontinuation of denosumab and associated fracture incidence: Analysis from the Fracture Reduction Evaluation of Denosumab in Osteoporosis Every 6 Months (FREEDOM) Trial
Jacques P. Brown et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2013)
Denosumab Densitometric Changes Assessed by Quantitative Computed Tomography at the Spine and Hip in Postmenopausal Women With Osteoporosis
Michael R. McClung et al.
JOURNAL OF CLINICAL DENSITOMETRY (2013)
Denosumab Significantly Increases DXA BMD at Both Trabecular and Cortical Sites: Results From the FREEDOM Study
Michael A. Bolognese et al.
JOURNAL OF CLINICAL DENSITOMETRY (2013)
Teriparatide and denosumab, alone or combined, in women with postmenopausal osteoporosis: the DATA study randomised trial
Joy N. Tsai et al.
LANCET (2013)
Osteoporosis Diagnosis and Medical Treatment
Amy H. Warriner et al.
ORTHOPEDIC CLINICS OF NORTH AMERICA (2013)
Effect of denosumab on bone mineral density and biochemical markers of bone turnover: 8-year results of a phase 2 clinical trial
M. R. McClung et al.
OSTEOPOROSIS INTERNATIONAL (2013)
Incidence, risk factors, and outcomes of osteonecrosis of the jaw: integrated analysis from three blinded active-controlled phase III trials in cancer patients with bone metastases
F. Saad et al.
ANNALS OF ONCOLOGY (2012)
Denosumab, a RANK Ligand Inhibitor, for Postmenopausal Women with Osteoporosis
Emily E. Sutton et al.
ANNALS OF PHARMACOTHERAPY (2012)
Concordance of preclinical and clinical pharmacology and toxicology of monoclonal antibodies and fusion proteins: soluble targets
Pauline L. Martin et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Role of RANK Ligand and Denosumab, a Targeted RANK Ligand Inhibitor, in Bone Health and Osteoporosis: A Review of Preclinical and Clinical Data
David W. Dempster et al.
CLINICAL THERAPEUTICS (2012)
Bisphosphonates in the Treatment of Osteoporosis
Dima L. Diab et al.
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (2012)
Early or Continued Osteoporosis Treatment During Nonvertebral Fracture-Healing: No Harm Done
Robert J Pignolo
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME (2012)
Denosumab Treatment in Postmenopausal Women with Osteoporosis Does Not Interfere with Fracture-Healing Results from the FREEDOM Trial
Silvano Adami et al.
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME (2012)
Time to onset of efficacy in fracture reduction with current anti-osteoporosis treatments
Charles A. Inderjeeth et al.
JOURNAL OF BONE AND MINERAL METABOLISM (2012)
Five years of denosumab exposure in women with postmenopausal osteoporosis: Results from the first two years of the FREEDOM extension
Socrates Papapoulos et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2012)
A single-dose study of denosumab in patients with various degrees of renal impairment
Geoffrey A. Block et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2012)
Incidence of Atypical Nontraumatic Diaphyseal Fractures of the Femur
Richard M. Dell et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2012)
New therapeutic targets for osteoporosis: Beyond denosumab
Vivien Lim et al.
MATURITAS (2012)
Infections in postmenopausal women with osteoporosis treated with denosumab or placebo: coincidence or causal association?
N. B. Watts et al.
OSTEOPOROSIS INTERNATIONAL (2012)
Final results of the DAPS (Denosumab Adherence Preference Satisfaction) study: a 24-month, randomized, crossover comparison with alendronate in postmenopausal women
N. Freemantle et al.
OSTEOPOROSIS INTERNATIONAL (2012)
The effects of osteoclast modifiers on the oral cavity: a review for prescribers
Matthew S. Epstein et al.
CURRENT OPINION IN SUPPORTIVE AND PALLIATIVE CARE (2012)
Skeletal and extraskeletal actions of denosumab
Kathrin Sinningen et al.
ENDOCRINE (2012)
Denosumab and bisphosphonates: Different mechanisms of action and effects
Roland Baron et al.
BONE (2011)
Denosumab for the Reduction of Bone Loss in Postmenopausal Osteoporosis: A Review
Mary Barna Bridgeman et al.
CLINICAL THERAPEUTICS (2011)
Effects of Denosumab on Fracture and Bone Mineral Density by Level of Kidney Function
Sophie A. Jamal et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2011)
Effects of Denosumab on Bone Turnover Markers in Postmenopausal Osteoporosis
Richard Eastell et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2011)
Treatment with Denosumab Reduces the Incidence of New Vertebral and Hip Fractures in Postmenopausal Women at High Risk
S. Boonen et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Effect of Denosumab on Bone Mineral Density and Biochemical Markers of Bone Turnover: Six-Year Results of a Phase 2 Clinical Trial
Paul D. Miller et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Denosumab-related osteonecrosis of the jaws
A. Kyrgidis et al.
OSTEOPOROSIS INTERNATIONAL (2011)
RANK ligand inhibition in bone metastatic cancer and risk of osteonecrosis of the jaw (ONJ): non bis in idem?
Tim Van den Wyngaert et al.
SUPPORTIVE CARE IN CANCER (2011)
Osteonecrosis of the jaws induced by anti-RANK ligand therapy
K. H. Taylor et al.
BRITISH JOURNAL OF ORAL & MAXILLOFACIAL SURGERY (2010)
Markers of bone resorption predict hip fracture in elderly women: The EPIDOS prospective study
P. Garnero et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Effects of Denosumab on Bone Mineral Density and Bone Turnover in Postmenopausal Women Transitioning From Alendronate Therapy
David L. Kendler et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Microarchitectural Deterioration of Cortical and Trabecular Bone: Differing Effects of Denosumab and Alendronate
Ego Seeman et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Atypical Subtrochanteric and Diaphyseal Femoral Fractures: Report of a Task Force of the American Society for Bone and Mineral Research
Elizabeth Shane et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Comparison of the Effect of Denosumab and Alendronate on BMD and Biochemical Markers of Bone Turnover in Postmenopausal Women With Low Bone Mass: A Randomized, Blinded, Phase 3 Trial
Jacques P. Brown et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2009)
Bisphosphonate Associated Osteonecrosis of the Jaw
Aliya A. Khan et al.
JOURNAL OF RHEUMATOLOGY (2009)
Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis
Steven R. Cummings et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Effect of denosumab on bone density and turnover in postmenopausal women with low bone mass after long-term continued, discontinued, and restarting of therapy: A randomized blinded phase 2 clinical trial
Paul D. Miller et al.
BONE (2008)
Phase 1 trial of denosumab safety, pharmacokinetics, and pharmacodynamics in Japanese women with breast cancer-related bone metastases
Kan Yonemori et al.
CANCER SCIENCE (2008)
Considerations for development of surrogate endpoints for antifracture efficacy of new treatments in osteoporosis: A perspective
Mary L. Bouxsein et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2008)
Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy
R. G. G. Russell et al.
OSTEOPOROSIS INTERNATIONAL (2008)
Epidermal RANKL controls regulatory T-cell numbers via activation of dendritic cells
Karin Loser et al.
NATURE MEDICINE (2006)
Compliance with drug therapy for postmenopausal osteoporosis
D. Weycker et al.
OSTEOPOROSIS INTERNATIONAL (2006)
Severely suppressed bone turnover: A potential complication of alendronate therapy
CV Odvina et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Effects of risedronate on trabecular microstructure and biomechanical properties in ovariectomized rat tibia
M Ito et al.
OSTEOPOROSIS INTERNATIONAL (2005)
Role of RANK ligand in mediating increased bone resorption in early postmenopausal women
G Eghbali-Fatourechi et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Role of receptor activator of nuclear factor-κB ligand and osteoprotegerin in bone cell biology
LC Hofbauer et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2001)
Share Paper
